loader2
Login Open ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations

Open ICICI
3-in-1 Account

Manage your Savings, Demat and Trading Account conveniently at one place

+91

BLOG

Aarti Pharmalabs has inaugurated an additional manufacturing block at Tarapur Unit

ICICIdirect Research 01 Jul 2026 DISCLAIMER

News: Aarti Pharmalabs has inaugurated an additional manufacturing block at Tarapur Unit V, Maharashtra, after receiving all necessary regulatory approvals to commence operations. The new facility adds 3,600 TPA of xanthine derivatives manufacturing capacity, increasing the company's total capacity to 9,600 TPA and positioning it among the top three global xanthine derivatives manufacturers.

View: This addition of a new block adds 50% to Aarti Pharmalabs's current Xanthine capacity. Xanthine segment during Q4FY26 witnessed growth mainly on back of increased capacity utilization of the existing 6000 MTPA. Trial production has commenced, with the facility expected to be ramped up over the next few quarters so we will keep a tab on the ramp-up of this new facility.

Impact: Positive

Download ICICI Direct app

Invest, Track, and Manage your Portfolio Anytime, Anywhere

Download ICICI Direct app

Invest, Track, and Manage your Portfolio Anytime, Anywhere